When was Omnicell founded?

Omnicell was founded in 1992 and raised its 1st funding round 3 years after it was founded.

Where is Omnicell located?

Omnicell is headquartered in Mountain View, United States.

Who is the current CEO of Omnicell?

Randy Lipps and Randall Lipps s of Omnicell. Randy Lipps has also founded 3 companies.

How many employees does Omnicell have?

As of Apr 30, 2026, the latest employee count at Omnicell is 3395.

Is Omnicell a funded company?

Omnicell is a funded company, having raised a total of $20M across 3 funding rounds to date. The company's 1st funding round was a $***** Unattributed round, raised on 1995.

When was the latest funding round of Omnicell?

Omnicell's latest funding was a $***** Post IPO round on May 22, 2017, with participation from 1 investor.

What is the annual revenue of Omnicell?

Annual revenue of Omnicell is $1.18B as on Dec 31, 2025.

Where does Omnicell rank among its competitors?

Omnicell ranks 1st amongst 72 active competitors, of which 17 are funded. It stands 6th in terms of total funding among its competitors. The most recent competitor to raise funding was Phil, which secured $60M in Jul, 2025.

Who are the top competitors of Omnicell?

Omnicell's top competitors include Alto, Phil and Kakehashi. Among them, Phil secured the most recent funding round in July, 2025.

Omnicell - 2026 Company Profile, Team, Funding, Competitors & Financials

Omnicell is a public company based in Mountain View (United States), founded in 1992 by Randy Lipps and Randall Lipps. It operates as a Developer of automated dispensing system for pharmacies. Omnicell has raised $20M in funding from ABS Capital. The company has 72 active competitors, including 17 funded and 10 that have exited. Its top competitors include companies like Alto, Phil and Kakehashi.

Company Details

Developer of automated dispensing system for pharmacies. It provides hardware/software systems for medication dispensing include solutions from the point of entry into the hospital through the central pharmacy, nursing unit, operating room, and patient bedside. The supply management systems promote cost control and charge capture for payer reimbursement, and improve management and reordering of inventory. Products range from high-security, closed-cabinet systems, and software to open-shelf and combination systems in the nursing unit, cath lab, and operating room.

Website: www.omnicell.com/
Social

Key Metrics

Founded Year

1992

Location

Mountain View, United States

Stage

Public

Total Funding

$20M in 3 rounds

Latest Funding Round

Post IPO, May 22, 2017, $*****

Investors

ABS Capital & 8 more

Ranked

1^st among 72 active competitors

Annual Revenue

$1.18B as on Dec 31, 2025

Employee Count

3,395 as on Apr 30, 2026

Investment & Acquisitions

Pharmaself24 & 10 more

Similar Companies

Alto & 84 more

Exit Details

Public

View Omnicell's full profile

Omnicell is associated with 6 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Omnicell, Inc. CIN: 943166458 , United States, Active	Dec 31, 1999	$1.18B (As on Dec 31, 2025)	3172 (As on Dec 31, 2024)	-
OMNICELL INDIA PRIVATE LIMITED CIN: U74999KA2021FTC147750 , India, Active	May 22, 2021	$9.19M (As on Mar 31, 2025)	-
Omnicell Limited CIN: 4562981 , Germany, Active	Oct 14, 2002	-	130 (As on Dec 31, 2019)
Omnicell, Inc CIN: 926326 , United States, Active	Apr 13, 2000	$1.13B (As on Dec 31, 2021)	-	-
OMNICELL INC CIN: 383496104 , United States, Active	Dec 31, 1999	-	19 (As on Dec 31, 2015)	-
Omnicell, Inc. CIN: 123451 , United States, Active	Jun 01, 2009	-	-	-

Omnicell got listed on Aug 07, 2001.

Click here to take a look at Omnicell's IPO in detail

Omnicell has raised a total funding of $20M over 3 rounds. Its first funding round was on 1995. Its latest funding round was a Post IPO round on May 22, 2017 for $*****. 1 investor participated in its latest round. Omnicell has 8 institutional investors and 1 angel investor.

Here is the list of recent funding rounds of Omnicell:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 22, 2017	7234089	Post IPO	2267545	3252945	9426790	1619978
Feb 17, 2000	9393543	Series B	9445897	6936163	7836559	Sutter Hill Ventures & 1 more
1995	7941	Unattributed	3643	5730	2117	Sequoia Capital

Access funding benchmarks and valuations. Sign up today!

View details of Omnicell's funding rounds and investors

The founders of Omnicell are Randy Lipps and Randall Lipps. Randall Lipps and Randy Lipps are the CEOs of Omnicell.

Here are the details of Omnicell's key team members:

Randy Lipps: Founder & CEO of Omnicell and founder of 3 other companies, Aesynt, EnlivenHealth and Omnicell.
Randall Lipps: Founder, CEO, Chairman & President of Omnicell.

View details of Omnicell's Founder profiles and Board Members

Omnicell's employee count trend

Omnicell has 3,395 employees as of Apr 26. Here is Omnicell's employee count trend over the years:

Uncover Omnicell's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Omnicell include Alto, Phil and Kakehashi. Here is the list of Top 10 competitors of Omnicell, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Omnicell 1992, Mountain View (United States), Public	Developer of automated dispensing system for pharmacies	$20M	ABS Capital, Synergy Ventures & 7 others	76/100
2nd	Alto 2015, San Francisco (United States), Acquired	Online pharmacy offering prescription delivery services	$592M	SoftBank Vision Fund, Greenoaks & 35 others	75/100
3rd	Phil 2015, San Francisco (United States), Series D	Technology-driven hub simplifying medication access and improving patient outcomes	$100M	Warburg Pincus, Crosslink Capital & 15 others	64/100
4th	Kakehashi 2016, Tokyo (Japan), Series D	Platform to provide point of care educational support to patient about their medications	$196M	Goldman Sachs, ITOCHU & 23 others	56/100
5th	Cureatr 2011, New York City (United States), Acquired	Provider of cloud-based medication management software for healthcare providers	$40.8M	Deerfield, Cardinal Partners & 7 others	54/100
6th	Strong Room 2017, Docklands (Australia), Seed	Provider of 3D facial mapping technology for biometrics solutions	-	Tyson & Blake, She1K & 3 others	52/100
7th	Healthera 2015, Cambridge (United Kingdom), Series A	Provider of medication adherence software for pharmacies and patients	$8.07M	Accelerated Digital Ventures, University of Cambridge ... & 15 others	48/100
8th	MDI 2018, Seattle (United States), Series A	AI-based medication management tool for healthcare professionals	$27M	Hanaco Ventures, Intel Capital & 7 others	48/100
9th	Ashtons 1995, Brighton (United Kingdom), Late Stage	Provider of medicines management and healthtech solutions	-	LDC	43/100
10th	MedAdvisor 2012, Camberwell (Australia), Public	Provider of medication management platform for pharmacies and patients	-	-	43/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Omnicell's competitors? Click here to see the top ones

Omnicell has not made any investments yet. Omnicell has made 11 acquisitions.

Here is the list of latest three $acquisitions:

Filter this list

Date of Investment/Acquisition	Type	Company Name	Founded Year	Location
Jan 17, 2022	Acquisition	Pharmaself24	2018	Leicester (United Kingdom)
Jan 04, 2022	Acquisition	Marketouch Media	2002	Houston (United States)
Dec 02, 2021	Acquisition	ReCept Pharmacy	1978	Grapevine (United States)